In studies of ALS patients, patients with lower levels of EphA4 protein correlated with later disease onset and individuals carrying mutations in the EPHA4 gene displayed increased survival rates [51]. The gene discussed is EPHA4; the disease is amyotrophic lateral sclerosis.